Medication comparison for slow stomach emptying in tube-fed hospital patients
Treatments studied
Part of Digestive system clinical trials.
This study compares two medications that help empty the stomach faster (itopride and metoclopramide) to see which works better for hospital patients with a high amount of leftover stomach contents while on tube feeding. If you qualify, you may receive one of these medications to help with digestion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and currently staying in the hospital.
- You are receiving nutrition through a feeding tube.
- Your doctor has measured a high amount of leftover stomach contents (200 ml or more).
- You have not taken a stomach-emptying medication (like metoclopramide or itopride) in the last 24 hours.
- You do not have certain heart conditions, recent stomach surgery, or a history of stomach bleeding or blockage.
- You are not pregnant and do not have Parkinson's disease or epilepsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at why some ICU patients have trouble with tube feeding (also called enteral nutrition). It aims to find better ways to detect and manage feeding intolerance, which is when a patient cannot tolerate food given through a tube into their stomach or intestines.
This trial compares two medicines, mosapride and metoclopramide, to see which one better helps patients in the intensive care unit (ICU) who have trouble digesting food given through a feeding tube. Both medicines are prokinetics, which help the stomach move food along.
This study compares two medicines, acotiamide and itopride, to see which works better for people with indigestion (a feeling of fullness after meals). If you have chronic post-meal fullness, you may find relief with one of these treatments.
This trial compares two medicines, acotiamide and itopride, to see which works better for postprandial distress syndrome—a digestive problem where you feel uncomfortably full after eating. If you have this condition, you may be eligible to participate.
This trial tests a medicine called itopride to see if it helps people with functional dyspepsia, a condition that causes stomach pain or fullness after eating. If you have this condition, the medicine might reduce your symptoms.
This study looks at how critically ill patients on a breathing tube and receiving nutrition through a tube tolerate their feeding, depending on the dose of medications given to manage their blood pressure. It aims to see if feeding works well while patients are on these medications.
Hear when a new Feeding Intolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.